Visiting the Bowelbabe Lab: Why tackling cancer must remain a government priority

In this blog, Michelle Mitchell, CEO of Cancer Research UK, talks about West Streeting 's recent visit to the Bowelbabe Lab.

Find a life worth enjoying; take risks; love deeply; have no regrets; and always, always have rebellious hope. These were Dame Deborah James’ inspirational words to us all, epitomising her positivity and strength in the darkest moments.  

Diagnosed with bowel cancer in 2016, Deborah shared her experience with honesty and humour, changing the conversation about cancer. Her impact is still felt today.   

In the final months of her life, Deborah called me with one final goal: to set up the Bowelbabe Fund for Cancer Research UK and raise £250,000. Three years on, that Fund has raised £17 million, touching countless lives. 

Thanks to research, more than half of those diagnosed with bowel cancer are expected to survive the disease. Breakthroughs from Cancer Research UK, such as genetic testing to see who is most at risk from bowel cancer, have been crucial. We continue to find new ways to detect, diagnose and treat cancer.   

Today, I met with the Secretary of State for Health and Social Care, Wes Streeting, at the Bowelbabe Lab in the Francis Crick Institute in London alongside Deborah’s family, who remain closely involved with the Fund. The lab focuses on developing new treatments for bowel cancer, exemplifying the hope being driven by research in her name.

Early diagnosis in bowel cancer is key: 90 percent survive five years or more if diagnosed in the earliest stage compared to 10 percent in the latest stage. Today’s visit aims to highlight why tackling cancer must remain a government priority.   

The Government’s 10-year health plan and National Cancer Plan for England can improve outcomes for all cancers. Reform and investment are essential to reduce cancer waiting lists; improve early cancer diagnosis and fund ground-breaking research.  

Dame Deborah’s legacy will continue to inspire. With the UK Government’s commitment, we can make significant strides for cancer patients. Let’s seize this opportunity.